Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ralf Wilkowski
Prognostic and Therapeutic Significance of Carbohydrate Antigen 19-9 as Tumor Marker in Patients With Pancreatic Cancer
Oncology
Medicine
Cancer Research
Oncology
Related publications
Pre-Treatment Carbohydrate Antigen 19-9 Does Not Predict the Response to Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer
HPB
Hepatology
Gastroenterology
A Case of Carbohydrate Antigen 19-9 Producing Gastric Cancer With Leucocytosis
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
A Case Report of Carbohydrate Antigen 19-9 Producing Advanced Gastric Cancer
Cancer and Clinical Oncology
Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer
Pancreas
Internal Medicine
Endocrinology
Hepatology
Metabolism
Diabetes
A Case of Gastric Carcinoma Producing Carbohydrate Antigen 19-9
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Carbohydrate Antigen 19-9 (CA19-9) Represents the Disease Activity of Nontuberculous Mycobacteria
Mycobacterial Diseases
Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics During Chemotherapy?
Oncology Research and Treatment
Cancer Research
Oncology
Hematology
Bronchogenic Cyst With High Carbohydrate Antigen 19-9 in the Cyst Fluid and the Serum.
Internal Medicine
Internal Medicine
Medicine
Estimating Prognosis and Palliation Based on Tumour Marker CA 19-9 and Quality of Life Indicators in Patients With Advanced Pancreatic Cancer Receiving Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
